Innovent Biologics Overview
Get informed when a big investor buys or sells
+ Follow198.23
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, IVBXF shows a PEG ratio of 198.23. That is above the Healthcare sector average of 27.75. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 27.75. Innovent Biologics is at 198.23, which is higher that average. That is roughly 614.3% above the sector mean. Use the comparison chart on this page to see how IVBXF stacks up against individual peers as well.
Investors watch IVBXF's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Innovent Biologics's latest reading is 198.23. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Innovent Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 198.23) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 27.75, while IVBXF is at 198.23. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
